Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (41-50 of 621) with videos related to

Pageof 63
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 8, 2023
Harnessing the multifunctionality of lipid-based drug delivery systems for the local treatment of osteoarthritisGregor Bordon, Francis Berenbaum, Oliver Distler, et al.
BMJ Case Reports|March 1, 2022
Self-monitoring of the resting heart rate using a fitness tracker smartwatch application leads to an early diagnosis of large vessel vasculitisNikitas Gkikopoulos, Mathias Wenger, Oliver Distler, et al.
Arthritis and Rheumatism|March 13, 2003
Minimum information about a microarray experiment: comment on the editorial by Firestein and PisetskyOliver Distler, Steffen Gay, Elena Neumann, et al.
International Reviews of Immunology|August 22, 2002
The molecular control of angiogenesisOliver Distler, Michel Neidhart, Renate E Gay, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|April 11, 2014
Visual problem and low back pain as initial manifestation of multiple myeloma complicating pre-existing systemic sclerosisMohammad Bagher Owlia, Oliver Distler, Mohammad Foratyazdi, et al.
Annals of the Rheumatic Diseases|October 7, 2020
Response to: 'Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'' by BredemeierJames R Seibold, Veronika Kohlbrenner, Margarida Alves, et al.
Nature Clinical Practice. Rheumatology|January 24, 2008
Diagnosis of pulmonary arterial hypertension in a patient with systemic sclerosisJörg H W Distler, Marius M Hoeper, Oliver Distler
The Lancet. Rheumatology|January 26, 2024
European consensus statements for interstitial lung disease in systemic sclerosis - Authors' replyAnna-Maria Hoffmann-Vold, Toby M Maher, Oliver Distler
The Journal of Rheumatology|July 1, 2024
Systemic Sclerosis Sine Scleroderma: A Time of ReappraisalAnastasios Makris, Alexandros Panagiotopoulos, Oliver Distler, et al.
Nature Clinical Practice. Rheumatology|January 5, 2007
Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implicationsOtylia Kowal-Bielecka, Krzysztof Kowal, Oliver Distler, et al.
Pageof 63

Showing results (41-50 of 621) with videos related to

Sort By:
Pageof 63
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 8, 2023
Harnessing the multifunctionality of lipid-based drug delivery systems for the local treatment of osteoarthritisGregor Bordon, Francis Berenbaum, Oliver Distler, et al.
BMJ Case Reports|March 1, 2022
Self-monitoring of the resting heart rate using a fitness tracker smartwatch application leads to an early diagnosis of large vessel vasculitisNikitas Gkikopoulos, Mathias Wenger, Oliver Distler, et al.
Arthritis and Rheumatism|March 13, 2003
Minimum information about a microarray experiment: comment on the editorial by Firestein and PisetskyOliver Distler, Steffen Gay, Elena Neumann, et al.
International Reviews of Immunology|August 22, 2002
The molecular control of angiogenesisOliver Distler, Michel Neidhart, Renate E Gay, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|April 11, 2014
Visual problem and low back pain as initial manifestation of multiple myeloma complicating pre-existing systemic sclerosisMohammad Bagher Owlia, Oliver Distler, Mohammad Foratyazdi, et al.
Annals of the Rheumatic Diseases|October 7, 2020
Response to: 'Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'' by BredemeierJames R Seibold, Veronika Kohlbrenner, Margarida Alves, et al.
Nature Clinical Practice. Rheumatology|January 24, 2008
Diagnosis of pulmonary arterial hypertension in a patient with systemic sclerosisJörg H W Distler, Marius M Hoeper, Oliver Distler
The Lancet. Rheumatology|January 26, 2024
European consensus statements for interstitial lung disease in systemic sclerosis - Authors' replyAnna-Maria Hoffmann-Vold, Toby M Maher, Oliver Distler
The Journal of Rheumatology|July 1, 2024
Systemic Sclerosis Sine Scleroderma: A Time of ReappraisalAnastasios Makris, Alexandros Panagiotopoulos, Oliver Distler, et al.
Nature Clinical Practice. Rheumatology|January 5, 2007
Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implicationsOtylia Kowal-Bielecka, Krzysztof Kowal, Oliver Distler, et al.
Pageof 63